Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future

The raising of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants led to the use of COVID‐19 bivalent vaccines, which include antigens of the wild‐type (WT) virus, and of the Omicron strain. In this study, we aimed to evaluate the impact of bivalent vaccination on the neutralizing...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2024-02, Vol.96 (2), p.e29416-n/a
Hauptverfasser:	Souza, Milena Silva, Farias, Jéssica Pires, Andreata‐Santos, Robert, Silva, Marianne Pereira, Brito, Ruth Dálety da Silva, Duarte Barbosa da Silva, Marcia, Peter, Cristina Mendes, Cirilo, Marcus Vinícius de França, Luiz, Wilson Barros, Birbrair, Alexander, Vidal, Paloma Oliveira, Castro‐Amarante, Maria Fernanda, Candido, Erika Donizetti, Munhoz, Aldilene Silva, Mello Malta, Fernanda, Dorlass, Erik Gustavo, Machado, Rafael Rahal Guaragna, Pinho, João Renato Rebello, Oliveira, Danielle Bruna Leal, Durigon, Edison Luiz, Maricato, Juliana Terzi, Braconi, Carla Torres, Ferreira, Luís Carlos de Souza, Janini, Luiz Mário Ramos, Amorim, Jaime Henrique
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibody response Antigens bivalent vaccine boost Coronaviruses COVID-19 COVID-19 vaccines epitope Epitopes Immunization Neutralization Neutralizing Omicron SARS‐CoV‐2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Vaccines Viral diseases Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!